{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T12:45:27Z","timestamp":1786193127299,"version":"build-2736575974"},"reference-count":54,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T00:00:00Z","timestamp":1780358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100015691","name":"National Institute of Allergy and Infectious Diseases Division of Microbiology and Infectious Diseases","doi-asserted-by":"publisher","award":["R21AI188438"],"award-info":[{"award-number":["R21AI188438"]}],"id":[{"id":"10.13039\/100015691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["P30AR070254"],"award-info":[{"award-number":["P30AR070254"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01AR079404"],"award-info":[{"award-number":["R01AR079404"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["P30 CA006973"],"award-info":[{"award-number":["P30 CA006973"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006093","name":"Patient-Centered Outcomes Research Institute","doi-asserted-by":"publisher","award":["IP2-PI000737"],"award-info":[{"award-number":["IP2-PI000737"]}],"id":[{"id":"10.13039\/100006093","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015629","name":"Jerome L Greene Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015629","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011541","name":"National Cancer Institute Division of Cancer Epidemiology and Genetics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.ard.2026.04.006","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T03:35:01Z","timestamp":1778643301000},"page":"1507-1519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anti-PAD4 antibodies link autoimmunity to PAD4 with CTL-associated rheumatoid arthritis"],"prefix":"10.1016","volume":"85","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0361-3465","authenticated-orcid":false,"given":"Kusuma","family":"Ananth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine B","family":"Moosic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Gomez-Banuelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Trejo-Zambrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramona","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica Marie","family":"Kirschmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tess","family":"Deddens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Elghawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryna","family":"Shemo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Kimpel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifton O","family":"Bingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J","family":"Feith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan","family":"Antiochos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Thomas P","family":"Loughran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1119-0279","authenticated-orcid":false,"given":"Erika","family":"Darrah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ard.2026.04.006_bib0001","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/BOR.0000000000000452","article-title":"Rheumatoid arthritis and citrullination","volume":"30","author":"Darrah","year":"2018","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"10.1016\/j.ard.2026.04.006_bib0002","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1172\/JCI1316","article-title":"Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies","volume":"101","author":"Schellekens","year":"1998","journal-title":"J Clin Invest."},{"issue":"1","key":"10.1016\/j.ard.2026.04.006_bib0003","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cca.2007.08.002","article-title":"Comparison of second- and third-generation anti-cyclic citrullinated peptide antibodies assays for detecting rheumatoid arthritis","volume":"386","author":"Lutteri","year":"2007","journal-title":"Clin Chim Acta"},{"issue":"2","key":"10.1016\/j.ard.2026.04.006_bib0004","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s10067-008-0999-5","article-title":"A comparative study of IgG second- and third-generation anti-cyclic citrullinated peptide (CCP) ELISAs and their combination with IgA third-generation CCP ELISA for the diagnosis of rheumatoid arthritis","volume":"28","author":"dos Anjos","year":"2009","journal-title":"Clin Rheumatol."},{"issue":"6","key":"10.1016\/j.ard.2026.04.006_bib0005","doi-asserted-by":"crossref","first-page":"4177","DOI":"10.4049\/jimmunol.166.6.4177","article-title":"The major synovial targets of the rheumatoid arthritis-specific antifilaggrin autoantibodies are deiminated forms of the alpha- and beta-chains of fibrin","volume":"166","author":"Masson-Bessi\u00e8re","year":"2001","journal-title":"J Immunol."},{"issue":"6","key":"10.1016\/j.ard.2026.04.006_bib0006","doi-asserted-by":"crossref","first-page":"R175","DOI":"10.1186\/ar2085","article-title":"Identification of novel citrullinated autoantigens of synovium in rheumatoid arthritis using a proteomic approach","volume":"8","author":"Matsuo","year":"2006","journal-title":"Arthritis Res Ther."},{"issue":"7","key":"10.1016\/j.ard.2026.04.006_bib0007","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1002\/art.23596","article-title":"Association of autoimmunity to peptidyl arginine deiminase type 4 with genotype and disease severity in rheumatoid arthritis","volume":"58","author":"Harris","year":"2008","journal-title":"Arthritis Rheum."},{"issue":"186","key":"10.1016\/j.ard.2026.04.006_bib0008","doi-asserted-by":"crossref","first-page":"186ra65","DOI":"10.1126\/scitranslmed.3005370","article-title":"Erosive rheumatoid arthritis is associated with antibodies that activate PAD4 by increasing calcium sensitivity","volume":"5","author":"Darrah","year":"2013","journal-title":"Sci Transl Med"},{"issue":"6","key":"10.1016\/j.ard.2026.04.006_bib0009","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/s41584-020-0409-1","article-title":"PAD enzymes in rheumatoid arthritis: pathogenic effectors and autoimmune targets","volume":"16","author":"Curran","year":"2020","journal-title":"Nat Rev Rheumatol."},{"issue":"3","key":"10.1016\/j.ard.2026.04.006_bib0010","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3899\/jrheum.180905","article-title":"Clinical utility of antipeptidyl arginine deiminase type 4 antibodies","volume":"46","author":"Darrah","year":"2019","journal-title":"J Rheumatol."},{"issue":"209","key":"10.1016\/j.ard.2026.04.006_bib0011","doi-asserted-by":"crossref","first-page":"209ra150","DOI":"10.1126\/scitranslmed.3006869","article-title":"Immune-mediated pore-forming pathways induce cellular hypercitrullination and generate citrullinated autoantigens in rheumatoid arthritis","volume":"5","author":"Romero","year":"2013","journal-title":"Sci Transl Med."},{"issue":"1","key":"10.1016\/j.ard.2026.04.006_bib0012","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1021\/acs.jproteome.6b00617","article-title":"Proteolysis by Granzyme B enhances presentation of autoantigenic peptidylarginine deiminase 4 epitopes in rheumatoid arthritis","volume":"16","author":"Darrah","year":"2017","journal-title":"J Proteome Res."},{"issue":"6","key":"10.1016\/j.ard.2026.04.006_bib0013","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1002\/art.41196","article-title":"Generation of distinct patterns of rheumatoid arthritis autoantigens by peptidylarginine deiminase types 2 and 4 during perforin-induced cell damage","volume":"72","author":"Romero","year":"2020","journal-title":"Arthritis Rheumatol."},{"issue":"8061","key":"10.1016\/j.ard.2026.04.006_bib0014","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/s41586-025-08713-9","article-title":"Granzyme K activates the entire complement cascade","volume":"641","author":"Donado","year":"2025","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.ard.2026.04.006_bib0015","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s10875-012-9674-3","article-title":"Characterization of effector memory CD8+ T cells in the synovial fluid of rheumatoid arthritis","volume":"32","author":"Cho","year":"2012","journal-title":"J Clin Immunol."},{"key":"10.1016\/j.ard.2026.04.006_bib0016","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms15869","article-title":"Somatic mutations in clonally expanded cytotoxic T lymphocytes in patients with newly diagnosed rheumatoid arthritis","volume":"8","author":"Savola","year":"2017","journal-title":"Nat Commun."},{"issue":"10","key":"10.1016\/j.ard.2026.04.006_bib0017","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1136\/ard.56.10.613","article-title":"Long-term persistent accumulation of CD8+ T cells in synovial fluid of rheumatoid arthritis","volume":"56","author":"Masuko-Hongo","year":"1997","journal-title":"Ann Rheum Dis."},{"issue":"2","key":"10.1016\/j.ard.2026.04.006_bib0018","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1046\/j.1365-2249.1999.00881.x","article-title":"The levels of soluble granzyme A and B are elevated in plasma and synovial fluid of patients with rheumatoid arthritis (RA)","volume":"116","author":"Tak","year":"1999","journal-title":"Clin Exp Immunol."},{"issue":"2","key":"10.1016\/j.ard.2026.04.006_bib0019","doi-asserted-by":"crossref","first-page":"220","DOI":"10.55563\/clinexprheumatol\/ffb107","article-title":"Increased intra-articular granzyme M may trigger local IFN-\u03bb1\/IL-29 response in rheumatoid arthritis","volume":"38","author":"Shan","year":"2020","journal-title":"Clin Exp Rheumatol."},{"issue":"1","key":"10.1016\/j.ard.2026.04.006_bib0020","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/s41467-022-35264-8","article-title":"Cytotoxic CD8+ T cells target citrullinated antigens in rheumatoid arthritis","volume":"14","author":"Moon","year":"2023","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.ard.2026.04.006_bib0021","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/hon.917","article-title":"The root of many evils: indolent large granular lymphocyte leukaemia and associated disorders","volume":"28","author":"Zhang","year":"2010","journal-title":"Hematol Oncol."},{"issue":"10","key":"10.1016\/j.ard.2026.04.006_bib0022","doi-asserted-by":"crossref","first-page":"2764","DOI":"10.1182\/blood-2010-07-296962","article-title":"How I treat LGL leukemia","volume":"117","author":"Lamy","year":"2011","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ard.2026.04.006_bib0023","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1182\/blood-2007-06-093823","article-title":"Antigen activation and impaired Fas-induced death-inducing signaling complex formation in T-large-granular lymphocyte leukemia","volume":"111","author":"Yang","year":"2008","journal-title":"Blood"},{"issue":"20","key":"10.1016\/j.ard.2026.04.006_bib0024","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1114885","article-title":"Somatic STAT3 Mutations in Large Granular Lymphocytic Leukemia","volume":"366","author":"Koskela","year":"2012","journal-title":"N Engl J Med."},{"issue":"3","key":"10.1016\/j.ard.2026.04.006_bib0025","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1172\/JCI9940","article-title":"Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression","volume":"107","author":"Epling-Burnette","year":"2001","journal-title":"J Clin Invest."},{"key":"10.1016\/j.ard.2026.04.006_bib0026","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.1","article-title":"Rheumatoid arthritis","volume":"4","author":"Smolen","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.ard.2026.04.006_bib0027","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.869205","article-title":"Intersection between large granular lymphocyte leukemia and rheumatoid arthritis","volume":"12","author":"Moosic","year":"2022","journal-title":"Front Oncol."},{"issue":"5","key":"10.1016\/j.ard.2026.04.006_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035296","article-title":"Autoantibody epitope spreading in the pre-clinical phase predicts progression to rheumatoid arthritis","volume":"7","author":"Sokolove","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.ard.2026.04.006_bib0029","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2024.1466276","article-title":"Activating STAT3 mutations in CD8+ T-cells correlate to serological positivity in rheumatoid arthritis","volume":"15","author":"Moosic","year":"2024","journal-title":"Front Immunol."},{"issue":"4","key":"10.1016\/j.ard.2026.04.006_bib0030","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/rheumatology\/kead545","article-title":"Diagnostic values, association with disease activity and possible risk factors of anti-PAD4 in rheumatoid arthritis: a meta-analysis","volume":"63","author":"Zhang","year":"2024","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"10.1016\/j.ard.2026.04.006_bib0031","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s13075-016-1126-7","article-title":"Association of anti-peptidyl arginine deiminase antibodies with radiographic severity of rheumatoid arthritis in African Americans","volume":"18","author":"Navarro-Mill\u00e1n","year":"2016","journal-title":"Arthritis Res Ther."},{"issue":"6","key":"10.1016\/j.ard.2026.04.006_bib0032","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/03009740410004990","article-title":"Peptidylarginine deiminase, the arginine to citrulline converting enzyme, is frequently recognized by sera of patients with rheumatoid arthritis, systemic lupus erythematosus and primary Sj\u00f6gren syndrome","volume":"32","author":"Nissinen","year":"2003","journal-title":"Scand J Rheumatol."},{"issue":"6","key":"10.1016\/j.ard.2026.04.006_bib0033","first-page":"969","article-title":"Prevalence and significance of anti-peptidylarginine deiminase 4 antibodies in rheumatoid arthritis","volume":"35","author":"Zhao","year":"2008","journal-title":"J Rheumatol."},{"issue":"5","key":"10.1016\/j.ard.2026.04.006_bib0034","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00296-010-1765-y","article-title":"Anti-PAD4 autoantibodies in rheumatoid arthritis: levels in serum over time and impact on PAD4 activity as measured with a small synthetic substrate","volume":"32","author":"Pollmann","year":"2011","journal-title":"Rheumatol Int."},{"issue":"2","key":"10.1016\/j.ard.2026.04.006_bib0035","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/acr2.11630","article-title":"Anti-peptidylarginine deiminase 4 autoantibodies and disease duration as predictors of treatment response in rheumatoid arthritis","volume":"6","author":"Cappelli","year":"2024","journal-title":"ACR Open Rheumatol."},{"issue":"4","key":"10.1016\/j.ard.2026.04.006_bib0036","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/ng1206","article-title":"Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis","volume":"34","author":"Suzuki","year":"2003","journal-title":"Nat Genet."},{"issue":"2","key":"10.1016\/j.ard.2026.04.006_bib0037","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/cei.12677","article-title":"Comparative analysis of autoantibodies targeting peptidylarginine deiminase type 4, mutated citrullinated vimentin and cyclic citrullinated peptides in rheumatoid arthritis: associations with cytokine profiles, clinical and genetic features","volume":"182","author":"Reyes-Castillo","year":"2015","journal-title":"Clin Exp Immunol."},{"issue":"9","key":"10.1016\/j.ard.2026.04.006_bib0038","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.3899\/jrheum.170769","article-title":"Lack of association among peptidyl arginine deiminase type 4 autoantibodies, PADI4 polymorphisms, and clinical characteristics in rheumatoid arthritis","volume":"45","author":"Guderud","year":"2018","journal-title":"J Rheumatol."},{"issue":"10","key":"10.1016\/j.ard.2026.04.006_bib0039","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.3390\/cells10102800","article-title":"Neutropenia and large granular lymphocyte leukemia: from pathogenesis to therapeutic options","volume":"10","author":"Calabretto","year":"2021","journal-title":"Cells"},{"issue":"37","key":"10.1016\/j.ard.2026.04.006_bib0040","doi-asserted-by":"crossref","first-page":"61876","DOI":"10.18632\/oncotarget.18711","article-title":"STAT3 mutation impacts biological and clinical features of T-LGL leukemia","volume":"8","author":"Teramo","year":"2017","journal-title":"Oncotarget"},{"issue":"4","key":"10.1016\/j.ard.2026.04.006_bib0041","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/s41375-019-0644-0","article-title":"Stat3 mutations impact on overall survival in large granular lymphocyte leukemia: a single-center experience of 205 patients","volume":"34","author":"Baril\u00e0","year":"2020","journal-title":"Leukemia"},{"issue":"4","key":"10.1016\/j.ard.2026.04.006_bib0042","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/s41375-021-01480-2","article-title":"miR-181a is a novel player in the STAT3-mediated survival network of TCR\u03b1\u03b2+ CD8+ T large granular lymphocyte leukemia","volume":"36","author":"Assmann","year":"2022","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.ard.2026.04.006_bib0043","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1309\/PH7X78HF4FW4PRKW","article-title":"T-cell large granular lymphocyte leukemias have multiple phenotypic abnormalities involving pan-T-cell antigens and receptors for MHC molecules","volume":"124","author":"Lundell","year":"2005","journal-title":"Am J Clin Pathol."},{"issue":"9","key":"10.1016\/j.ard.2026.04.006_bib0044","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1182\/blood-2016-08-692590","article-title":"LGL leukemia: from pathogenesis to treatment","volume":"129","author":"Lamy","year":"2017","journal-title":"Blood"},{"issue":"6","key":"10.1016\/j.ard.2026.04.006_bib0045","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1309\/A8FHDA0VVRJ05GJP","article-title":"T-cell large granular leukemia and related proliferations","volume":"127","author":"O'Malley","year":"2007","journal-title":"Am J Clin Pathol."},{"issue":"18","key":"10.1016\/j.ard.2026.04.006_bib0046","doi-asserted-by":"crossref","first-page":"4513","DOI":"10.3390\/cancers13184513","article-title":"The value of flow cytometry clonality in large granular lymphocyte leukemia","volume":"13","author":"Giudice","year":"2021","journal-title":"Cancers (Basel)"},{"issue":"7","key":"10.1016\/j.ard.2026.04.006_bib0047","doi-asserted-by":"crossref","first-page":"745","DOI":"10.6061\/clinics\/2012(07)07","article-title":"T-cell large granular lymphocytic leukemia: treatment experience with fludarabine","volume":"67","author":"Costa","year":"2012","journal-title":"Clinics (Sao Paulo)"},{"issue":"5","key":"10.1016\/j.ard.2026.04.006_bib0048","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1136\/ard.57.5.319","article-title":"TCR beta spectratyping in RA: evidence of clonal expansions in peripheral blood lymphocytes","volume":"57","author":"Hall","year":"1998","journal-title":"Ann Rheum Dis."},{"issue":"2","key":"10.1016\/j.ard.2026.04.006_bib0049","doi-asserted-by":"crossref","first-page":"852","DOI":"10.4049\/jimmunol.156.2.852","article-title":"Oligoclonality of V beta 3 TCR chains in the CD8+ T cell population of rheumatoid arthritis patients","volume":"156","author":"Hingorani","year":"1996","journal-title":"J Immunol."},{"issue":"5","key":"10.1016\/j.ard.2026.04.006_bib0050","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1002\/art.1780360506","article-title":"Increased percentage of CD3+, CD57+ lymphocytes in patients with rheumatoid arthritis. Correlation with duration of disease","volume":"36","author":"Dupuy d\u2019Angeac","year":"1993","journal-title":"Arthritis Rheum."},{"issue":"7","key":"10.1016\/j.ard.2026.04.006_bib0051","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/s41590-019-0378-1","article-title":"Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry","volume":"20","author":"Zhang","year":"2019","journal-title":"Nat Immunol."},{"issue":"2","key":"10.1016\/j.ard.2026.04.006_bib0052","doi-asserted-by":"crossref","first-page":"86","DOI":"10.7555\/JBR.33.20190075","article-title":"Contribution of neutrophils in the pathogenesis of rheumatoid arthritis","volume":"34","author":"Zhang","year":"2020","journal-title":"J Biomed Res."},{"issue":"10","key":"10.1016\/j.ard.2026.04.006_bib0053","doi-asserted-by":"crossref","first-page":"3219","DOI":"10.1182\/blood.V95.10.3219","article-title":"Chronic neutropenia mediated by Fas ligand","volume":"95","author":"Liu","year":"2000","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.ard.2026.04.006_bib0054","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nm0396-317","article-title":"Fas ligand in human serum","volume":"2","author":"Tanaka","year":"1996","journal-title":"Nat Med."}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672600230X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000349672600230X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,8]],"date-time":"2026-08-08T12:28:03Z","timestamp":1786192083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000349672600230X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":54,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S000349672600230X"],"URL":"https:\/\/doi.org\/10.1016\/j.ard.2026.04.006","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-PAD4 antibodies link autoimmunity to PAD4 with CTL-associated rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ard.2026.04.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Alliance of Associations for Rheumatology (EULAR).","name":"copyright","label":"Copyright"}]}}